She started treatment with etanercept (Enbrel ®) 1 month previously. One day after a subcutaneous injection into the left thigh, she developed a mildly pruritic eruption on the right thigh ...

Etanercept is a biologic medicine used to treat a range of disabling inflammatory diseases. Sandoz alleges that Amgen blocked competition from more cost-effective biosimilar competitors ...

Etanercept is a biologic medicine used to treat a range of disabling inflammatory diseases. Sandoz alleges that Amgen blocked competition from more cost-effective biosimilar competitors, including ...

In April 2025, Sandoz announced the filing of an antitrust lawsuit in the US against Amgen, Inc. (Amgen), for extending and entrenching the dominant market position of Enbrel®[5] (etanercept), first ...

Etanercept is a biologic medicine used to treat a range of disabling inflammatory diseases. Sandoz alleges that Amgen blocked competition from more cost-effective biosimilar competitors ...

In the 2019 ENTRACTE study, patients receiving either tocilizumab or etanercept, a TNF inhibitor, had no significant differences in risk of major adverse cardiovascular events (HR, 1.05 ...

Alston & Bird on behalf of a rival pharma company alleges Amgen prevented would-be competitors from entering the U.S. product market for etanercept in violation of the Sherman Act. Representing ...

Alston & Bird on behalf of a rival pharma company alleges Amgen prevented would-be competitors from entering the U.S. product market for etanercept in violation of the Sherman Act. Representing ...

In children with juvenile rheumatoid arthritis who show continued response to etanercept, the drug can be given safely for at least 8 years. Traditional treatment for juvenile rheumatoid arthritis ...

Shares of NASDAQ BIIB opened at $122.98 on Friday. The company has a 50 day simple moving average of $140.68 and a 200 day simple moving average of $157.62. The company has a debt-to-equity ratio ...